-
公开(公告)号:WO0020441A3
公开(公告)日:2000-11-23
申请号:PCT/US9922844
申请日:1999-10-01
Applicant: ABBOTT LAB
Inventor: WANG WEI-BO , LI QUN , HASVOLD LISA A , CHEN HUI-JU , LI LEPING , LARTEY PAUL A , CLAIBORNE AKIYO , STEINER BETH A , BENNANI YOUSSEF , DICKMAN DANIEL , DING HONG
IPC: C07C67/343 , C07D295/155 , C07K7/56 , A61K38/12 , A61P33/08
CPC classification number: C07D295/155 , C07C67/343 , C07K7/56 , C07C69/94
Abstract: The invention relates to a novel cyclic hexapeptide having antifungal and antipneumocystic activity as well as pharmaceutical compositions comprising, methods of treating using, and a process for preparing the claimed compounds.
Abstract translation: 本发明涉及具有抗真菌和抗肺囊虫活性的新型环状六肽以及药物组合物,其包含使用方法和制备所要求保护的化合物的方法。
-
2.
公开(公告)号:WO2010065824A3
公开(公告)日:2010-10-07
申请号:PCT/US2009066722
申请日:2009-12-04
Applicant: ABBOTT LAB , BRUNCKO MILAN , DAI YUJIA , DING HONG , DOHERTY GEORGE A , ELMORE STEVEN W , HASVOLD LISA , HEXAMER LAURA , KUNZER AARON R , MANTEI ROBERT A , MCCLELLAN WILLIAM J , PARK CHANG H , PARK CHEOL-MIN , PETROS ANDREW M , SONG XIAOHONG , SOUERS ANDREW J , SULLIVAN GERARD M , TAO ZHI-FU , WANG GARY T , WANG LE , WANG XILU , WENDT MICHAEL D
Inventor: BRUNCKO MILAN , DAI YUJIA , DING HONG , DOHERTY GEORGE A , ELMORE STEVEN W , HASVOLD LISA , HEXAMER LAURA , KUNZER AARON R , MANTEI ROBERT A , MCCLELLAN WILLIAM J , PARK CHANG H , PARK CHEOL-MIN , PETROS ANDREW M , SONG XIAOHONG , SOUERS ANDREW J , SULLIVAN GERARD M , TAO ZHI-FU , WANG GARY T , WANG LE , WANG XILU , WENDT MICHAEL D
IPC: A61P35/00 , A61K31/496 , C07D403/12
CPC classification number: C07D405/12 , C07D209/08 , C07D211/58 , C07D213/74 , C07D213/84 , C07D231/56 , C07D235/06 , C07D277/24 , C07D295/30 , C07D309/04 , C07D401/14 , C07D405/14 , C07D413/12 , C07D417/12 , C07D471/04
Abstract: Disclosed are compounds which inhibit the activity of anti-apoptotic Bcl-2 proteins, compositions containing the compounds and methods of treating diseases during which is expressed anti-apoptotic Bcl-2 protein.
-
3.APOPTOSIS-INDUCING AGENTS FOR THE TREATMENT OF CANCER AND IMMUNE AND AUTOIMMUNE DISEASES 审中-公开
Title translation: 细胞凋亡诱导剂治疗癌症和免疫及自身免疫疾病公开(公告)号:WO2010138588A3
公开(公告)日:2011-04-07
申请号:PCT/US2010036198
申请日:2010-05-26
Applicant: ABBOTT LAB , BRUNCKO MILAN , DING HONG , DOHERTY GEORGE , ELMORE STEVEN , HASVOLD LISA , HEXAMER LAURA , KUNZER AARON R , SONG XIAOHONG , SOUERS ANDREW J , SULLIVAN GERARD , TAO ZHI-FU , WANG GARY T , WANG LE , WANG XILU , WENDT MICHAEL , MANTEI ROBERT , HANSEN TODD M
Inventor: BRUNCKO MILAN , DING HONG , DOHERTY GEORGE , ELMORE STEVEN , HASVOLD LISA , HEXAMER LAURA , KUNZER AARON R , SONG XIAOHONG , SOUERS ANDREW J , SULLIVAN GERARD , TAO ZHI-FU , WANG GARY T , WANG LE , WANG XILU , WENDT MICHAEL , MANTEI ROBERT , HANSEN TODD M
IPC: C07D471/04 , A61K31/437 , A61P35/00
CPC classification number: C07D471/04 , C07D491/052 , C07D519/00
Abstract: Disclosed are compounds which inhibit the activity of anti-apoptotic Bcl-2 proteins, compositions containing the compounds and methods of treating diseases during which is expressed anti-apoptotic Bcl-2 protein.
Abstract translation: 公开了抑制抗凋亡Bcl-2蛋白活性的化合物,含有该化合物的组合物和治疗表达抗凋亡Bcl-2蛋白的疾病的方法。
-
公开(公告)号:WO2007008627A2
公开(公告)日:2007-01-18
申请号:PCT/US2006026424
申请日:2006-07-07
Applicant: ABBOTT LAB , WENDT MICHAEL D , SHEN WANG , DICKMAN DANIEL A , DING HONG , THOMAS SHEELA A , AUGERI DAVID , ELMORE STEVEN W
Inventor: WENDT MICHAEL D , SHEN WANG , DICKMAN DANIEL A , DING HONG , THOMAS SHEELA A , AUGERI DAVID , ELMORE STEVEN W
IPC: A61K31/192 , A61P35/00 , C07C15/12
CPC classification number: C07C311/41 , C07C63/48 , C07C63/49 , C07C65/26 , C07C65/28 , C07C205/58 , C07C229/52 , C07C229/56 , C07C233/81 , C07C311/13 , C07C311/18 , C07C311/21 , C07C311/37 , C07C311/44 , C07C323/20 , C07C323/25 , C07C323/62 , C07C2601/08 , C07C2601/14 , C07C2601/18 , C07C2602/10 , C07C2603/18 , C07C2603/74 , C07D207/30 , C07D213/53 , C07D215/12 , C07D215/48 , C07D333/34
Abstract: Compounds which inhibit the activity of anti-apoptotic Mcl-1 protein, compositions containing the compounds and methods of treating diseases during which are expressed the Mcl-1 protein are disclosed.
Abstract translation: 公开了抑制抗细胞凋亡Mcl-1蛋白活性的化合物,含有该化合物的组合物和治疗疾病的方法,其表达为Mcl-1蛋白。
-
5.APOPTOSIS-INDUCING AGENTS FOR THE TREATMENT OF CANCER AND IMMUNE AND AUTOIMMUNE DISEASES 审中-公开
Title translation: 用于治疗癌症和免疫和自发性疾病的病毒诱导剂公开(公告)号:WO2010138588A9
公开(公告)日:2011-05-05
申请号:PCT/US2010036198
申请日:2010-05-26
Applicant: ABBOTT LAB , BRUNCKO MILAN , DING HONG , DOHERTY GEORGE , ELMORE STEVEN , HASVOLD LISA , HEXAMER LAURA , KUNZER AARON R , SONG XIAOHONG , SOUERS ANDREW J , SULLIVAN GERARD , TAO ZHI-FU , WANG GARY T , WANG LE , WANG XILU , WENDT MICHAEL , MANTEI ROBERT , HANSEN TODD M
Inventor: BRUNCKO MILAN , DING HONG , DOHERTY GEORGE , ELMORE STEVEN , HASVOLD LISA , HEXAMER LAURA , KUNZER AARON R , SONG XIAOHONG , SOUERS ANDREW J , SULLIVAN GERARD , TAO ZHI-FU , WANG GARY T , WANG LE , WANG XILU , WENDT MICHAEL , MANTEI ROBERT , HANSEN TODD M
IPC: C07D471/04 , A61K31/437 , A61P35/00
CPC classification number: C07D471/04 , C07D491/052 , C07D519/00
Abstract: Disclosed are compounds which inhibit the activity of anti-apoptotic Bcl-2 proteins, compositions containing the compounds and methods of treating diseases during which is expressed anti-apoptotic Bcl-2 protein.
Abstract translation: 公开了抑制抗凋亡Bcl-2蛋白活性的化合物,含有化合物的组合物和治疗疾病的方法,其中表达抗凋亡Bcl-2蛋白。
-
6.APOPTOSIS-INDUCING AGENTS FOR THE TREATMENT OF CANCER AND IMMUNE AND AUTOIMMUNE DISEASES 审中-公开
Title translation: 用于治疗癌症和免疫和自发性疾病的病毒诱导剂公开(公告)号:WO2010083441A3
公开(公告)日:2010-09-10
申请号:PCT/US2010021243
申请日:2010-01-15
Applicant: ABBOTT LAB , HEXAMER LAURA , DING HONG , ELMORE STEVEN W , KUNZER AARON R , SONG XIAOHONG , SOUERS ANDREW J , SULLIVAN GERARD M , TAO ZHI-FU , WENDT MICHAEL D
Inventor: HEXAMER LAURA , DING HONG , ELMORE STEVEN W , KUNZER AARON R , SONG XIAOHONG , SOUERS ANDREW J , SULLIVAN GERARD M , TAO ZHI-FU , WENDT MICHAEL D
IPC: C07D209/08 , A61K31/635 , A61P35/00 , C07D213/71 , C07D231/56 , C07D235/04 , C07D265/02 , C07D285/14 , C07D295/155 , C07D311/14
CPC classification number: C07D295/155 , C07D209/08 , C07D213/71 , C07D231/56 , C07D235/04 , C07D265/02 , C07D285/14 , C07D311/14
Abstract: Disclosed are compounds of formula (I) which inhibit the activity of anti-apoptotic Bcl-2 proteins, compositions containing the compounds and methods of treating diseases during which is expressed anti-apoptotic Bcl-2 protein.
Abstract translation: 公开了抑制抗凋亡Bcl-2蛋白活性的式(I)化合物,含有该化合物的组合物和治疗其中表达抗凋亡Bcl-2蛋白的疾病的方法。
-
7.APOPTOSIS-INDUCING AGENTS FOR THE TREATMENT OF CANCER AND IMMUNE AND AUTOIMMUNE DISEASES 审中-公开
Title translation: 用于治疗癌症和免疫和自发性疾病的病毒诱导剂公开(公告)号:WO2011119345A2
公开(公告)日:2011-09-29
申请号:PCT/US2011027895
申请日:2011-03-10
Applicant: ABBOTT LAB , DING HONG , ELMORE STEVEN , HEXAMER LAURA , KUNZER AARON R , PARK CHEOL-MIN , SOUERS ANDREW J , SULLIVAN GERARD , WENDT MICHAEL
Inventor: DING HONG , ELMORE STEVEN , HEXAMER LAURA , KUNZER AARON R , PARK CHEOL-MIN , SOUERS ANDREW J , SULLIVAN GERARD , WENDT MICHAEL
IPC: C07D295/195 , A61K31/18 , A61K31/451 , A61K31/495 , A61P35/00 , C07C311/51 , C07D211/58
CPC classification number: C07D211/58 , C07C311/51 , C07C2601/14 , C07C2603/74 , C07D295/112 , C07D295/195 , C07D417/04
Abstract: Disclosed are compounds which inhibit the activity of anti-apoptotic Bcl-2 proteins, compositions containing the compounds and methods of treating diseases during which is expressed anti apoptotic Bcl-2 protein.
Abstract translation: 公开了抑制抗凋亡Bcl-2蛋白活性的化合物,含有这些化合物的组合物和治疗其中表达抗凋亡Bcl-2蛋白的疾病的方法。
-
8.SULFONAMIDE DERIVATIVES AS BCL-2-SELECTIVE APOPTOSIS-INDUCING AGENTS FOR THE TREATMENT OF CANCER AND IMMUNE DISEASES 审中-公开
Title translation: 作为治疗癌症和免疫疾病的BCL-2-选择性病毒诱导剂的磺酰胺衍生物公开(公告)号:WO2010065865A3
公开(公告)日:2010-09-16
申请号:PCT/US2009066790
申请日:2009-12-04
Applicant: ABBOTT LAB , BRUNCKO MILAN , DING HONG , DOHERTY GEORGE A , ELMORE STEVEN W , HASVOLD LISA , HEXAMER LAURA , KUNZER AARON R , MANTEI ROBERT A , MCCLELLAN WILLIAM J , PARK CHANG H , PARK CHEOL-MIN , PETROS ANDREW M , SONG XIAOHONG , SOUERS ANDREW J , SULLIVAN GERARD M , TAO ZHI-FU , WANG GARY T , WANG LE , WANG XILU , WENDT MICHAEL D
Inventor: BRUNCKO MILAN , DING HONG , DOHERTY GEORGE A , ELMORE STEVEN W , HASVOLD LISA , HEXAMER LAURA , KUNZER AARON R , MANTEI ROBERT A , MCCLELLAN WILLIAM J , PARK CHANG H , PARK CHEOL-MIN , PETROS ANDREW M , SONG XIAOHONG , SOUERS ANDREW J , SULLIVAN GERARD M , TAO ZHI-FU , WANG GARY T , WANG LE , WANG XILU , WENDT MICHAEL D
IPC: C07D405/12 , A61K31/404 , A61P35/00 , C07D209/32 , C07D211/96 , C07D213/64 , C07D215/20 , C07D217/16 , C07D235/26 , C07D249/04 , C07D295/125 , C07D295/14 , C07D309/14 , C07D401/12
CPC classification number: C07D405/12 , C07D209/32 , C07D211/96 , C07D213/64 , C07D215/20 , C07D217/16 , C07D231/56 , C07D235/26 , C07D249/04 , C07D295/125 , C07D295/14 , C07D309/14 , C07D401/12 , C07D417/12
Abstract: Disclosed are compounds of formula (I) which inhibit the activity of anti-apoptotic BcI -2 or BcI -xL proteins, compositions containing the compounds and methods of treating diseases during which are expressed anti -aooptotic Bcl-2 protein.
Abstract translation: 公开了抑制抗凋亡BcI -2或BcI-xL蛋白活性的式(I)化合物,含有该化合物的组合物和治疗其中表达抗细胞凋亡Bcl-2蛋白的疾病的方法。
-
公开(公告)号:WO2007040650A9
公开(公告)日:2007-07-26
申请号:PCT/US2006018799
申请日:2006-05-12
Applicant: ABBOTT LAB , BRUNCKO MILAN , DING HONG , ELMORE STEVEN W , KUNZER AARON R , LYNCH CHRISTOPHER L , MCCELLAN WILLIAM J , PARK CHEOL MIN , SONG XIAHONG , WANG XILU
Inventor: BRUNCKO MILAN , DING HONG , ELMORE STEVEN W , KUNZER AARON R , LYNCH CHRISTOPHER L , MCCELLAN WILLIAM J , PARK CHEOL MIN , SONG XIAHONG , WANG XILU
IPC: C07D295/14 , A61K31/496 , A61P35/00 , C07D487/08 , C07D491/08
CPC classification number: C07D295/155 , C07D487/08 , C07D491/08
Abstract: Compounds which inhibit the activity of anti-apoptotic family protein members, compositions containing the compounds and methods of treating diseases during which occur expression one or more than one of an anti?apoptotic family protein member are disclosed.
Abstract translation: 公开了抑制抗凋亡家族蛋白成员活性的化合物,含有该化合物的组合物和治疗疾病的方法,其中发生表达一种或多种抗β凋亡家族蛋白质成员。
-
公开(公告)号:WO0224636A3
公开(公告)日:2002-09-26
申请号:PCT/US0129432
申请日:2001-09-20
Applicant: ABBOTT LAB
Inventor: MCCLELLAN WILLIAM , OOST THORSTEN , BRUNCKO MILAN , WANG XILU , AUGERI DAVID J , BAUMEISTER STEVEN A , DICKMAN DANIEL A , DING HONG , DINGES JURGEN , FESIK STEPHEN W , HAJDUK PHILIP J , KUNZER AARON R , NETTESHEIM DAVID G , PETROS ANDREW M , ROSENBERG SAUL H , SHEN WANG , THOMAS SHEELA A , WENDT MICHAEL D
IPC: A61K31/18 , A61K31/428 , A61K31/63 , A61K31/635 , A61P9/10 , A61P25/16 , A61P25/28 , A61P29/00 , A61P31/12 , A61P31/18 , A61P35/00 , A61P37/02 , C07C311/46 , C07C311/51 , C07C317/28 , C07C323/12 , C07C323/17 , C07C323/25 , C07C323/30 , C07C323/37 , C07C323/43 , C07C323/44 , C07C323/48 , C07C323/58 , C07C323/60 , C07D203/10 , C07D205/04 , C07D205/12 , C07D207/09 , C07D207/24 , C07D207/40 , C07D207/404 , C07D209/08 , C07D209/52 , C07D209/54 , C07D209/96 , C07D211/14 , C07D211/44 , C07D211/70 , C07D211/74 , C07D213/56 , C07D213/61 , C07D213/64 , C07D213/69 , C07D213/70 , C07D213/71 , C07D215/14 , C07D215/22 , C07D215/227 , C07D215/38 , C07D215/48 , C07D217/04 , C07D221/20 , C07D231/12 , C07D233/60 , C07D235/08 , C07D235/26 , C07D241/08 , C07D241/16 , C07D249/04 , C07D263/32 , C07D263/56 , C07D263/58 , C07D277/62 , C07D277/64 , C07D295/13 , C07D295/155 , C07D295/16 , C07D295/185 , C07D295/20 , C07D295/205 , C07D295/215 , C07D295/26 , C07D307/14 , C07D317/54 , C07D333/28 , C07D333/68 , C07D333/70 , C07D401/06 , C07D401/12 , C07D405/04 , C07D405/06 , C07D417/12 , C07D451/02 , C07D491/107 , C07D295/14 , C07D317/58
CPC classification number: C07D207/404 , C07C311/51 , C07C317/28 , C07C323/12 , C07C323/17 , C07C323/25 , C07C323/30 , C07C323/37 , C07C323/58 , C07C323/60 , C07C2601/08 , C07C2601/14 , C07C2601/16 , C07C2601/18 , C07C2602/08 , C07C2602/10 , C07C2602/28 , C07C2602/42 , C07C2602/44 , C07C2603/74 , C07D203/10 , C07D205/12 , C07D207/24 , C07D209/08 , C07D209/96 , C07D211/44 , C07D211/70 , C07D211/74 , C07D213/61 , C07D213/70 , C07D213/71 , C07D215/14 , C07D215/227 , C07D215/48 , C07D217/04 , C07D221/20 , C07D231/12 , C07D235/08 , C07D235/26 , C07D241/16 , C07D249/04 , C07D263/56 , C07D263/58 , C07D277/62 , C07D277/64 , C07D295/13 , C07D295/155 , C07D295/185 , C07D295/205 , C07D295/215 , C07D295/26 , C07D307/14 , C07D317/54 , C07D333/28 , C07D333/68 , C07D401/06 , C07D401/12 , C07D405/04 , C07D417/12 , C07D451/02
Abstract: N-Benzoyl arylsulfonamides having the formula (I) are BCL-Xl inhibitors and are useful for promoting apoptosis. Also disclosed are BCL-Xl inhibiting compositions and methods of promoting apoptosis in a mammal.
Abstract translation: 具有式(I)的N-苯甲酰基芳基磺酰胺是BCL-X1抑制剂,可用于促进细胞凋亡。 还公开了BCL-X1抑制组合物和促进哺乳动物细胞凋亡的方法。
-
-
-
-
-
-
-
-
-